within Pharmacolibrary.Drugs.ATC.M;

model M02AA23
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.9,
    Cl             = 0.0011666666666666668,
    adminDuration  = 600,
    adminMass      = 0.05,
    adminCount     = 1,
    Vd             = 0.00034,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 10.200000000000001
  );

  annotation(Documentation(
    info ="<html><body><p>Indometacin (also known as indomethacin) is a nonsteroidal anti-inflammatory drug (NSAID) used primarily for the treatment of pain, inflammation, and fever. It is indicated in conditions such as rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and acute gouty arthritis. It is an approved drug, but not typically considered first-line due to its potential gastrointestinal and cardiovascular side effects.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers following oral administration.</p><h4>References</h4><ol><li><p>Derry, S, et al., &amp; Moore, RA (2017). Topical analgesics for acute and chronic pain in adults - an overview of Cochrane Reviews. <i>The Cochrane database of systematic reviews</i> 5(5) CD008609–None. DOI:<a href=&quot;https://doi.org/10.1002/14651858.CD008609.pub2&quot;>10.1002/14651858.CD008609.pub2</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28497473/&quot;>https://pubmed.ncbi.nlm.nih.gov/28497473</a></p></li><li><p>Alván, G, et al., &amp; Palmér, L (1975). Pharmacokinetics of indomethacin. <i>Clinical pharmacology and therapeutics</i> 18(3) 364–373. DOI:<a href=&quot;https://doi.org/10.1002/cpt1975183364&quot;>10.1002/cpt1975183364</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1100305/&quot;>https://pubmed.ncbi.nlm.nih.gov/1100305</a></p></li><li><p>Sharma, PK, et al., &amp; Narang, A (2003). Pharmacokinetics of oral ibuprofen in premature infants. <i>Journal of clinical pharmacology</i> 43(9) 968–973. DOI:<a href=&quot;https://doi.org/10.1177/0091270003254635&quot;>10.1177/0091270003254635</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12971028/&quot;>https://pubmed.ncbi.nlm.nih.gov/12971028</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end M02AA23;
